Author:
Späth Martin R.,Kann Martin,Kurschat Christine E.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Alhamad T, Venkatachalam K, Linette GP et al (2016) Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection. Am J Transplant 16:1332–1333
2. Andrés A (2005) Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 56:71–85
3. Au E, Wong G, Chapman JR (2018) Cancer in kidney transplant recipients. Nat Rev Nephrol 14:508–520
4. Cherikh WS, Kauffman HM, Mcbride MA et al (2003) Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1. Transplantation 76:
5. Coppolino G, Simeoni M, Rivoli L et al (2015) Kidney and Neoplastic Disease: Overview with a Particular Interest to Interpretation of Cancer Biomarkers. In: Patel VB (Hrsg) Biomarkers in Kidney Disease. Springer, Netherlands, Dordrecht, S 1–20